Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
PLD DRE EXR BMR Office Supplies Railroads Long-Short Biotech 
United States  USA  |  Investing Themes


Processing
Collecting data for BMR

BioMed quote and profile

 
 Companies |  Insiders  | Dashboard  
     
22.65
  
STOCK
(0.11)  Macroaxis: -0.48 Down   0.48%  
Year To Date
17.5223.13
Trading Day 
22.622.94
May 19 2013 

Diversification Suggestion

Use BioMed to protect against small markets fluctuations. The stock experiences normal downward trend and little activity
Analyze BioMed Realty Trust Trend or Check current 30 days BioMed correlation with market (S&P 500)
1 Month Beta 0.7  
Highest Price:  
Lowest Price:  
23.09  
22.25  
May 15 2013 
May 09 2013 
As returns on market increase, BioMed returns are expected to increase less than the market. However during bear market, the loss on holding BioMed will be expected to be smaller as well.
BioMed Realty Trust Inc Small BetaBioMed Realty Trust Beta Legend
BMR United States NYSE
BioMed Realty Trust Inc
Financial
REIT - Industrial
http://www.biomedrealty.com
Contact Number: 858. 485. 9840
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation5.81 B
Shares Outstanding152.77 M
Number of Shares Shorted6.28 M
Revenue516.78 M
 United States Russel   1.11 % Macroaxis: change 1.11 Moved Up  
 
 United States SP 500   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States NYSE   0.92 % Macroaxis: 0.92 Moved Up  
 
 thisRed BMR BMR agains markets  0.48 % Macroaxis: 0.48 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

BioMed Leadership

Alan Gold Chairman and CEO, MBA
Gary Kreitzer Executive Vice President General Counsel, Director
Karen Sztraicher Executive Vice President - Asset Management
R Griffin President COO

BioMed Price and Market Media

The median price of BioMed for the period between Fri, Apr 19, 2013 and Sun, May 19, 2013 is 22.5 with a coefficient of variation of 0.98. The daily time series for the period is distributed with a sample standard deviation of 0.22, arithmetic mean of 22.56, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period.
BioMed         Market
Price Growth (%)
 
1
BIOMED REALTY TRUST INC BioMed Realty Trust To Report 2013 F...04/24/2013Macroaxis: News
2
BioMed Realty Trust to Develop 297000 SF04/26/2013Macroaxis: News
3
BioMed Realty Trust Q1 FFO Rises Lifts FY13 Earnings Outlook...05/02/2013Macroaxis: News
4
Wexford to spend 150 on second phase of downtown project05/10/2013Macroaxis: News
5
BioMed Realty Trust Upgraded to Buy by Stifel Nicolaus05/14/2013Macroaxis: News
6
Senior Housing Properties Trust Management Presents at Bank ...05/16/2013Macroaxis: Seeking Alpha News

BioMed Summary

BioMed Realty Trust Inc [BMR] is traded on New York Stock Exchange in USA. It is located in San Diego, CA and employs 175 people. The company currently falls under 'Mid-Cap' category with total capitalization of 3.43 B. BioMed Realty Trust Inc runs under Financial sector within REIT - Industrial industry. This company has 152.77 M outstanding shares of which 6.28 M shares are currently shorted by investors with about 3.3 days to cover shorted positions.
BioMed Realty Trust, Inc. operates as a real estate investment trust that focuses on providing real estate to the life science industry in the United States. more
Past Market
Over 30
Days
2
Out Of
100
 
Chance of
Less
Than
47 %
 
Follow BioMed with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add BioMed to your reader
 

BioMed Research Report

BioMed vs. Prologis

Correlation analysis and fundamentals comparison between BioMed Realty Trust and Prologis Inc

BioMed Executives

Greg CPA CFO
Greg Lubushkin CFO
Kent Griffin Pres and COO

BioMed Directors

Barbara Cambon Independent Director, MBA
Gary JD Executive VP and Director
M Wilson Independent Director
Daniel Bradbury Director
Richard Gilchrist Independent Director

BioMed Management

Matthew McDevitt Executive VP of Real Estate

BioMed Fundamentals

Current Valuation vs Price to Book
Earnings Per Share vs Net Income
Current Valuation vs Cash per Share
Retained Earnings vs Net Income

BioMed vs Competition

BioMed vs. Prologis Inc
BioMed vs. Duke Realty Corporation
BioMed vs. Extra Space Storage Inc
BioMed vs. DCT Industrial Trust Inc
BioMed vs. Sovran Self Storage Inc
BioMed vs. Potlatch Corporation
BioMed vs. EastGroup Properties Inc
BioMed vs. First Industrial Realty Trust Inc
BioMed vs. Monmouth Real Estate Investment Corp

BioMed May 19 2013 Opportunity Range

Downside Deviation0.9057
Information Ratio(0.36)
Maximum Drawdown3.12
Value At Risk(1.43)
Potential Upside1.08

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium